GeneSet Information

Tier IV GS409537 • Predicted genetically driven gene expression from gSEM GWAS in substantia nigra of opioid addiction cases vs. controls_pvalue

DESCRIPTION:

The genomic structural equation modeling (gSEM) analysis includes results on european ancestry (EA) from the Genetics of Opioid Addiction Consortium (GENOA) meta-analysis, Million Veteran Program (MVP), Psychiatric Genetics Consortium Substance Use Disorders Group (PGC-SUD), and the Partners Health cohorts. The MVP results are based on a meta-analysis including MVP parts 1 and 2 (total of 8529 OUD cases and 71,200 opioid-exposed controls), along with Yale-Penn and Study of Addiction: Genetics and Environment (SAGE) cohorts (total of 10,544 OUD cases and 72,163 opioid-exposed controls). The PGC-SUD results include 4,503 opioid dependence cases and 4173 unexposed controls. Unexposed controls are used for the PGC-SUD because the exposed controls results have negative heritability estimates. The partners health cohort includes 1,039 OUD cases and 10,743 exposed controls. Note that the GENOA GWAS, Yale-Penn, and SAGE parts of the MVP, and the PGC-SUD results include overlapping samples. However, accounting for this sample overlap is a feature of the gSEM approach applied in this study. A total of 2,434,903 variants were present in all cohorts and tested for association with the OA latent variable in the gSEM analysis using a total sample size of 403,915 (23,367 cases and 384,619 controls; effective sample size of 88,114). We applied S-PrediXcan using GTEx version 8 eQTL gene models (http://predictdb.org/) with the gSEM GWAS summary statistics as input to estimate genetically driven differential gene expression in human brain tissues associated with opioid addiction (OA). Fourteen gene-tissue combinations surpassed correction for the total number of gene models and brain tissues (156,215 tests) with a false discovery rate (FDR) less than 0.05 (Table 1; all results presented in Supplementary Table 14). Genes and pvalues presented include those with all FDR values.

LABEL:

Predicted DEG from gSEM GWAS in substantia nigra of OA cases vs. controls_pvalue

SCORE TYPE:

P-Value

THRESHOLD:

<= 0.5

GENES IN THRESHOLD:

5126

DATE ADDED:

2024-12-02

DATE UPDATED:

2025-06-06

SPECIES:

AUTHORS:

Nathan Gaddis, Ravi Mathur, Jesse Marks, Linran Zhou, Bryan Quach, Alex Waldrop, Orna Levran, Arpana Agrawal, Matthew Randesi, Miriam Adelson, Paul W Jeffries, Nicholas G Martin, Louisa Degenhardt, Grant W Montgomery, Leah Wetherill, Dongbing Lai, Kathleen Bucholz, Tatiana Foroud, Bernice Porjesz, Valgerdur Runarsdottir, Thorarinn Tyrfingsson, Gudmundur Einarsson, Daniel F Gudbjartsson, Bradley Todd Webb, Richard C Crist, Henry R Kranzler, Richard Sherva, Hang Zhou, Gary Hulse, Dieter Wildenauer, Erin Kelty, John Attia, Elizabeth G Holliday, Mark McEvoy, Rodney J Scott, Sibylle G Schwab, Brion S Maher, Richard Gruza, Mary Jeanne Kreek, Elliot C Nelson, Thorgeir Thorgeirsson, Kari Stefansson, Wade H Berrettini, Joel Gelernter, Howard J Edenberg, Laura Bierut, Dana B Hancock, Eric Otto Johnson

TITLE:

Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond.

JOURNAL:

Scientific reports Oct 2022, Vol 12, pp. 16873

ABSTRACT:

Opioid addiction (OA) is moderately heritable, yet only rs1799971, the A118G variant in OPRM1, has been identified as a genome-wide significant association with OA and independently replicated. We applied genomic structural equation modeling to conduct a GWAS of the new Genetics of Opioid Addiction Consortium (GENOA) data together with published studies (Psychiatric Genomics Consortium, Million Veteran Program, and Partners Health), comprising 23,367 cases and effective sample size of 88,114 individuals of European ancestry. Genetic correlations among the various OA phenotypes were uniformly high (r PUBMED: 36207451
Find other GeneSets from this publication

Annotation Information

No sequence read archive data associated with this GeneSet.


Meta-Analysis (D017418)
Genetics (D005823)
Substance-Related Disorders (D019966)
Opioid-Related Disorders (D009293)
Gene Expression (D015870)
Tissues (D014024)
Genomics (D023281)
Association (D001244)
Analgesics, Opioid (D000701)
Veterans (D014728)
addiction (MP:0002555)
gene expression (GO:0010467)
Transcriptomics (EDAM_topic:0203)
prostaglandins C (CHEBI:26336)
propyzamide (CHEBI:34935)
opioid dependence (EFO:0005611)
Caucasian (EFO:0003156)
serial analysis of gene expression assay (MMO:0000660)
adult cerebral ganglion (UBERON:6110636)

Gene List • 10872 Genes

Genes in threshold: 5126

Uploaded As Gene Symbol Homology Score Priority LinkOuts Emphasis